Key Financial Inc’s Editas Medicine EDIT Stock Holding History

Key Financial Inc’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243	Hold	75	–	–	﹤0.01%	1302
2026 Q1	$185	Hold	75	–	–	﹤0.01%	1346
2025 Q4	$154	Hold	75	–	–	﹤0.01%	1392
2025 Q3	$266	Hold	75	–	–	﹤0.01%	1385
2025 Q2	$165	Hold	75	–	–	﹤0.01%	1385
2025 Q1	$87	Hold	75	–	–	﹤0.01%	1360
2024 Q4	$95	Hold	75	–	–	﹤0.01%	1358
2024 Q3	$256	Hold	75	–	–	﹤0.01%	1300
2024 Q2	$350	Hold	75	–	–	﹤0.01%	1278
2024 Q1	$556	Hold	75	–	–	﹤0.01%	1218
2023 Q4	$760	Sell	75 -11	-13%	-$97	﹤0.01%	1206
2023 Q3	$671	Hold	86	–	–	﹤0.01%	1229
2023 Q2	$708	Hold	86	–	–	﹤0.01%	1269
2023 Q1	$624	Hold	86	–	–	﹤0.01%	1076
2022 Q4	$1.05K	Hold	86	–	–	﹤0.01%	1027
2022 Q3	$1K	Hold	86	–	–	﹤0.01%	1018
2022 Q2	$1K	Hold	86	–	–	﹤0.01%	1004
2022 Q1	$2K	Hold	86	–	–	﹤0.01%	918
2021 Q4	$2K	Hold	86	–	–	﹤0.01%	816
2021 Q3	$4K	Hold	86	–	–	﹤0.01%	731
2021 Q2	$4K	Hold	86	–	–	﹤0.01%	704
2021 Q1	$4K	Sell	86 -64	-43%	-$3.65K	﹤0.01%	617
2020 Q4	$11K	Buy	+150	New	+$6.16K	0.01%	445

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Key Financial Inc's EDIT Position: Q2 2026 in Review

Key Financial Inc held its Editas Medicine (EDIT) position steady in Q2 2026 at 75 shares worth $243. The position accounts for ﹤0.01% of the portfolio, ranked #1302.

Key Financial Inc first reported a position in EDIT in Q4 2020 and has held it in 23 quarters since. The position peaked at $11K in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Key Financial Inc held 75 shares of Editas Medicine worth $243 as of Q2 2026.
Key Financial Inc left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1302 holding.
Key Financial Inc first reported a position in Editas Medicine in Q4 2020 and has held it in 23 quarters since.
Key Financial Inc's Editas Medicine position peaked at $11K in Q4 2020.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.